Immunõ 2026: Where Is Cancer Immunotherapy Heading Next?
FDA Approves Imlunestrant Plus Abemaciclib for ESR1-Mutated Advanced Breast Cancer After Endocrine Therapy
Highlights from SIOP 2026
Atezolizumab Plus Gemcitabine/Cisplatin in Metastatic Urothelial Cancer
Robin Zon: ASCO Highlights Medicaid Policy Changes and Continuity of Cancer Care
Patrizia Giannatempo: A New Perioperative Era in MIBC
STAS in Stage I Lung Adenocarcinoma Is More Than a Histologic Finding: Multi-Omic Profiling Reveals an Aggressive Molecular Phenotype
WHO Flags Six Essential Childhood Cancer Medicines Facing Critical Access Gaps
The Caring for the Cancer Patient 2026 will take place on November 5–7, 2026, at the Fairmont Scottsdale Princess in Scottsdale, Arizona, USA, with livestream participation available. The course is […]
